New concept on blood lipid management promotes the development of clinical blood lipid test

Abstract

Dyslipidemia is one of the important risk factors for cardiovascular and cerebrovascular diseases. Extensive evidence has proven that effective control of dyslipidemia can reduce the incidence and mortality of cardiovascular and cerebrovascular diseases.In recent years, related research in the field of blood has been quite active.The guidelines for the management of dyslipidemia in Europe, the United States, and China have been successively updated.Although there are some disagreements on whether the LDL-C should reach the target value and whether blood lipid testing needs fasting, all of these new guidelines emphasize the importance of controlling blood lipid levels in different risk stratification groups, also emphasize that lipid-lowering therapy should be patient-centered to improve patient compliance. At present, most of the laboratory report of blood lipid test results in China cannot meet the requirements of different therapeutic targets for patients with different risk groups in the Guidelines for the management of blood lipids . How to make the reasonable blood lipid reference range better reflected in the clinical test report form, is also one of the directions that future laboratory physicians need to work hard on. (Chin J Lab Med, 2018, 41: 409-414) Key words: Cardiovascular diseases; Lipids; Reference values; Cholesterol, LDL